Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210759 (US9290454, 4.4) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet  | PC cid PC sid UniChem | US Patent | 5.16 | -51.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210749 (US9290454, 3.1) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 5.79 | -51.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210750 (US9290454, 3.2) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 6.50 | -50.6 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210764 (US9290454, 7.2) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 7.79 | -50.2 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210751 (US9290454, 3.3) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 8.20 | -50.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210752 (US9290454, 3.4) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 8.84 | -49.8 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210760 (US9290454, 5.1) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 10.2 | -49.4 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210767 (US9290454, 8.1) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 10.9 | -49.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210765 (US9290454, 7.3) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 12.7 | -48.8 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210753 (US9290454, 3.5) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 13.1 | -48.8 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210757 (US9290454, 4.2) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 13.6 | -48.7 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210768 (US9290454, 8.2) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 14.8 | -48.4 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210766 (US9290454, 7.4) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 14.8 | -48.4 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210769 (US9290454, 8.3) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 17.0 | -48.1 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210771 (US9290454, 8.5) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 17.2 | -48.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210772 (US9290454, 8.6) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 17.3 | -48.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210754 (US9290454, 3.6 | US9290454, 3.7) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 18.7 | -47.8 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210758 (US9290454, 4.3) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 20.7 | -47.5 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210763 (US9290454, 7.1) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 21.5 | -47.4 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210756 (US9290454, 4.1) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 22.5 | -47.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210762 (US9290454, 6.2) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 25.4 | -47.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210770 (US9290454, 8.4) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 37.2 | -46.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210746 (US9290454, 1.1) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 37.7 | -45.9 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210747 (US9290454, 1.2) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 49.0 | -45.2 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210761 (US9290454, 6.1) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 79.1 | -43.9 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210754 (US9290454, 3.6 | US9290454, 3.7) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 363 | -39.8 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Prostaglandin D2 receptor 2 (Homo sapiens (Human)) | BDBM210748 (US9290454, 2.1) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 4.92E+3 | -32.8 | n/a | n/a | n/a | n/a | n/a | 7.4 | 50 |
Merck Sharp & Dohme Corp. US Patent | Assay Description Radioligand binding was performed using filtration or scintillation proximity assay (SPA) technology. SPA assays were done at room temperature in 10 ... | US Patent US9290454 (2016) BindingDB Entry DOI: 10.7270/Q2W66JMQ | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
